信迪利单抗-话题@MedSci

#信迪利单抗#

9篇内容 | 2966人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2227826, encodeId=b27a222e826b5, content=<a href='/topic/show?id=c3f910342343' target=_blank style='color:#2F92EE;'>#鼻咽癌#</a> <a href='/topic/show?id=329c2e376fa' target=_blank style='color:#2F92EE;'>#信迪利单抗#</a>, objectTitle=读书报告 | CONTINUUM研究：信迪利单抗联合同步诱导放化疗治疗中国局部晚期鼻咽癌的3 期临床试验, objectType=article, longId=843456, objectId=204284345649, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240924/1727155704875_8538692.png, objectUrl=/article/show_article.do?id=204284345649, replyNumber=0, likeNumber=62, createdTime=2024-09-26, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=204284345649, moduleTitle=读书报告 | CONTINUUM研究：信迪利单抗联合同步诱导放化疗治疗中国局部晚期鼻咽癌的3 期临床试验, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=204284345649)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2226977, encodeId=e2e422269e742, content=<a href='/topic/show?id=32af9938ec6' target=_blank style='color:#2F92EE;'>#非小细胞肺癌#</a> <a href='/topic/show?id=329c2e376fa' target=_blank style='color:#2F92EE;'>#信迪利单抗#</a>, objectTitle=EGFR 19del/T790M/C797S顺式突变耐药非小细胞肺癌获益信迪利单抗/抗VEGF/化疗, objectType=article, longId=844131, objectId=26c68441315f, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240920/1726800373067_8538692.png, objectUrl=/article/show_article.do?id=26c68441315f, replyNumber=0, likeNumber=27, createdTime=2024-09-22, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=26c68441315f, moduleTitle=EGFR 19del/T790M/C797S顺式突变耐药非小细胞肺癌获益信迪利单抗/抗VEGF/化疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=26c68441315f)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2224794, encodeId=ac5b2224e94cd, content=<a href='/topic/show?id=674769813be' target=_blank style='color:#2F92EE;'>#甲氨蝶呤#</a> <a href='/topic/show?id=820e3228e1b' target=_blank style='color:#2F92EE;'>#利妥昔单抗#</a> <a href='/topic/show?id=6a1c60356fb' target=_blank style='color:#2F92EE;'>#替莫唑胺#</a> <a href='/topic/show?id=f7603e0370d' target=_blank style='color:#2F92EE;'>#原发性中枢神经系统淋巴瘤#</a> <a href='/topic/show?id=329c2e376fa' target=_blank style='color:#2F92EE;'>#信迪利单抗#</a>, objectTitle=【STTT】信迪利单抗、大剂量甲氨蝶呤、替莫唑胺和利妥昔单抗治疗PCNSL的2期研究, objectType=article, longId=842351, objectId=9fbc8423516f, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240722/1721615892206_92910.jpg, objectUrl=/article/show_article.do?id=9fbc8423516f, replyNumber=0, likeNumber=39, createdTime=2024-09-09, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=9fbc8423516f, moduleTitle=【STTT】信迪利单抗、大剂量甲氨蝶呤、替莫唑胺和利妥昔单抗治疗PCNSL的2期研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9fbc8423516f)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2224466, encodeId=b0c022244668b, content=<a href='/topic/show?id=c3f910342343' target=_blank style='color:#2F92EE;'>#鼻咽癌#</a> <a href='/topic/show?id=329c2e376fa' target=_blank style='color:#2F92EE;'>#信迪利单抗#</a>, objectTitle=读书报告 | CONTINUUM研究：信迪利单抗联合诱导-同步放化疗治疗中国局部晚期鼻咽癌患者的多中心随机对照的3 期临床试验, objectType=article, longId=841863, objectId=1ac7841863b6, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240906/1725586111557_8538692.png, objectUrl=/article/show_article.do?id=1ac7841863b6, replyNumber=0, likeNumber=38, createdTime=2024-09-06, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=1ac7841863b6, moduleTitle=读书报告 | CONTINUUM研究：信迪利单抗联合诱导-同步放化疗治疗中国局部晚期鼻咽癌患者的多中心随机对照的3 期临床试验, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1ac7841863b6)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2222463, encodeId=235d2222463e5, content=<a href='/topic/show?id=f9e2832202f' target=_blank style='color:#2F92EE;'>#胃癌#</a> <a href='/topic/show?id=5df56936690' target=_blank style='color:#2F92EE;'>#生物标志物#</a> <a href='/topic/show?id=329c2e376fa' target=_blank style='color:#2F92EE;'>#信迪利单抗#</a>, objectTitle=吴昊教授：精准诊疗在胃癌围手术期及晚期的应用, objectType=article, longId=840653, objectId=15dd840653ed, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240725/1721894656535_92910.jpg, objectUrl=/article/show_article.do?id=15dd840653ed, replyNumber=0, likeNumber=67, createdTime=2024-08-26, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=15dd840653ed, moduleTitle=吴昊教授：精准诊疗在胃癌围手术期及晚期的应用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=15dd840653ed)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2219858, encodeId=af462219858bc, content=<a href='/topic/show?id=51cbe247518' target=_blank style='color:#2F92EE;'>#直肠癌#</a> <a href='/topic/show?id=329c2e376fa' target=_blank style='color:#2F92EE;'>#信迪利单抗#</a> <a href='/topic/show?id=f8c411e810ba' target=_blank style='color:#2F92EE;'>#新辅助同步放化疗#</a>, objectTitle=徐瑞华团队研究荣登《Cancer Cell》：新辅助同步放化疗联合信迪利单抗为pMMR局部进展期直肠癌患者提供新选择！, objectType=article, longId=838692, objectId=fc56838692e9, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240711/1720665035747_5579292.png, objectUrl=/article/show_article.do?id=fc56838692e9, replyNumber=0, likeNumber=73, createdTime=2024-08-13, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=fc56838692e9, moduleTitle=徐瑞华团队研究荣登《Cancer Cell》：新辅助同步放化疗联合信迪利单抗为pMMR局部进展期直肠癌患者提供新选择！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fc56838692e9)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2219236, encodeId=9a6b2219236c2, content=<a href='/topic/show?id=329c2e376fa' target=_blank style='color:#2F92EE;'>#信迪利单抗#</a> <a href='/topic/show?id=53cd11e69136' target=_blank style='color:#2F92EE;'>#术前放疗化疗#</a> <a href='/topic/show?id=1e7411e69229' target=_blank style='color:#2F92EE;'>#pMMR局部晚期结直肠癌#</a>, objectTitle=Cancer Cell | 添加信迪利单抗到术前化疗放疗可显著提高 pMMR 局部晚期直肠癌患者的 CR 率, objectType=article, longId=838237, objectId=c87183823e12, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240722/1721641334629_92910.png, objectUrl=/article/show_article.do?id=c87183823e12, replyNumber=0, likeNumber=48, createdTime=2024-08-09, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=c87183823e12, moduleTitle=Cancer Cell | 添加信迪利单抗到术前化疗放疗可显著提高 pMMR 局部晚期直肠癌患者的 CR 率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c87183823e12)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2211467, encodeId=05e6221146e7e, content=<a href='/topic/show?id=735a81364b7' target=_blank style='color:#2F92EE;'>#肝细胞癌#</a> <a href='/topic/show?id=329c2e376fa' target=_blank style='color:#2F92EE;'>#信迪利单抗#</a>, objectTitle=读书报告 | 信迪利单抗辅助治疗高危肝细胞癌的II期临床研究, objectType=article, longId=830895, objectId=388083089570, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240622/1719058467451_5579292.jpg, objectUrl=/article/show_article.do?id=388083089570, replyNumber=0, likeNumber=85, createdTime=2024-06-24, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=388083089570, moduleTitle=读书报告 | 信迪利单抗辅助治疗高危肝细胞癌的II期临床研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=388083089570)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2207144, encodeId=7743220e1447c, content=<a href='/topic/show?id=d38c905431c' target=_blank style='color:#2F92EE;'>#西达苯胺#</a> <a href='/topic/show?id=81bae855273' target=_blank style='color:#2F92EE;'>#结外NK/T细胞淋巴瘤#</a> <a href='/topic/show?id=329c2e376fa' target=_blank style='color:#2F92EE;'>#信迪利单抗#</a>, objectTitle=信迪利单抗联合西达苯胺在复发/难治性结外NK/T细胞淋巴瘤中的Ib/II期研究, objectType=article, longId=825977, objectId=1c188259e77c, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240527/1716793947080_5579292.png, objectUrl=/article/show_article.do?id=1c188259e77c, replyNumber=0, likeNumber=128, createdTime=2024-05-28, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=1c188259e77c, moduleTitle=信迪利单抗联合西达苯胺在复发/难治性结外NK/T细胞淋巴瘤中的Ib/II期研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1c188259e77c)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2206375, encodeId=560922063e542, content=<a href='/topic/show?id=330410333110' target=_blank style='color:#2F92EE;'>#黑色素瘤#</a> <a href='/topic/show?id=c3aa4e516d6' target=_blank style='color:#2F92EE;'>#尿路上皮癌#</a> <a href='/topic/show?id=329c2e376fa' target=_blank style='color:#2F92EE;'>#信迪利单抗#</a> <a href='/topic/show?id=baf1114805aa' target=_blank style='color:#2F92EE;'>#IBI310#</a>, objectTitle=The innovation：IBI310(抗CTLA-4抗体)单药或联合信迪利单抗治疗晚期黑色素瘤或尿路上皮癌的I期研究, objectType=article, longId=827222, objectId=7be982e222b2, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240524/1716514226108_92910.png, objectUrl=/article/show_article.do?id=7be982e222b2, replyNumber=0, likeNumber=101, createdTime=2024-05-24, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=7be982e222b2, moduleTitle=The innovation：IBI310(抗CTLA-4抗体)单药或联合信迪利单抗治疗晚期黑色素瘤或尿路上皮癌的I期研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7be982e222b2)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2205701, encodeId=5f212205e01cb, content=<a href='/topic/show?id=634d90542d9' target=_blank style='color:#2F92EE;'>#西达本胺#</a> <a href='/topic/show?id=81bae855273' target=_blank style='color:#2F92EE;'>#结外NK/T细胞淋巴瘤#</a> <a href='/topic/show?id=329c2e376fa' target=_blank style='color:#2F92EE;'>#信迪利单抗#</a> <a href='/topic/show?id=87771146e18e' target=_blank style='color:#2F92EE;'>#ENKTL#</a>, objectTitle=STTT：信迪利单抗+西达本胺治疗复发/难治ENKTL的I/II期SCENT研究, objectType=article, longId=826676, objectId=3cba8266e6a3, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240520/1716187063136_5579292.jpg, objectUrl=/article/show_article.do?id=3cba8266e6a3, replyNumber=0, likeNumber=110, createdTime=2024-05-20, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=3cba8266e6a3, moduleTitle=STTT：信迪利单抗+西达本胺治疗复发/难治ENKTL的I/II期SCENT研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3cba8266e6a3)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2205109, encodeId=0740220510931, content=<a href='/topic/show?id=493ae869206' target=_blank style='color:#2F92EE;'>#结直肠癌#</a> <a href='/topic/show?id=0a9e922085f' target=_blank style='color:#2F92EE;'>#贝伐珠单抗#</a> <a href='/topic/show?id=634d90542d9' target=_blank style='color:#2F92EE;'>#西达本胺#</a> <a href='/topic/show?id=329c2e376fa' target=_blank style='color:#2F92EE;'>#信迪利单抗#</a>, objectTitle=读书报告 | PD1抗体联合HADC抑制剂和VEGF抑制剂治疗pMMR/MSS晚期结直肠癌的II期临床研究, objectType=article, longId=826154, objectId=75bd82615412, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240516/1715867323870_1608702.png, objectUrl=/article/show_article.do?id=75bd82615412, replyNumber=0, likeNumber=0, createdTime=2024-05-16, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=75bd82615412, moduleTitle=读书报告 | PD1抗体联合HADC抑制剂和VEGF抑制剂治疗pMMR/MSS晚期结直肠癌的II期临床研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=75bd82615412)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2197043, encodeId=9e5c219e043b0, content=<a href='/topic/show?id=e13a13585eb' target=_blank style='color:#2F92EE;'>#P-Gemox#</a> <a href='/topic/show?id=81bae855273' target=_blank style='color:#2F92EE;'>#结外NK/T细胞淋巴瘤#</a> <a href='/topic/show?id=329c2e376fa' target=_blank style='color:#2F92EE;'>#信迪利单抗#</a>, objectTitle=Lancet Haematol：信迪利单抗联合P-GEMOX一线治疗晚期ENKTL的多中心、单臂、2期研究, objectType=article, longId=820235, objectId=1e508202353d, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20221109/1668017232524_4754896.png, objectUrl=/article/show_article.do?id=1e508202353d, replyNumber=0, likeNumber=87, createdTime=2024-04-05, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=1e508202353d, moduleTitle=Lancet Haematol：信迪利单抗联合P-GEMOX一线治疗晚期ENKTL的多中心、单臂、2期研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1e508202353d)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2196972, encodeId=126321969e283, content=<a href='/topic/show?id=5e2e4e08988' target=_blank style='color:#2F92EE;'>#小细胞肺癌#</a> <a href='/topic/show?id=02982402298' target=_blank style='color:#2F92EE;'>#二线治疗#</a> <a href='/topic/show?id=a20e45830e0' target=_blank style='color:#2F92EE;'>#安罗替尼#</a> <a href='/topic/show?id=329c2e376fa' target=_blank style='color:#2F92EE;'>#信迪利单抗#</a>, objectTitle=中国科研之声 | 王启鸣教授团队探索高效低毒方案，研究成果在顶级医学期刊发表，为广泛期SCLC患者开辟二线治疗新路径, objectType=article, longId=820285, objectId=94428202852a, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/doctor-filling-form-U2MAYRK.jpg, objectUrl=/article/show_article.do?id=94428202852a, replyNumber=0, likeNumber=119, createdTime=2024-04-04, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=陕西省, moduleDTOList=[ModuleDTO(moduleId=94428202852a, moduleTitle=中国科研之声 | 王启鸣教授团队探索高效低毒方案，研究成果在顶级医学期刊发表，为广泛期SCLC患者开辟二线治疗新路径, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=94428202852a)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2195049, encodeId=19ca2195049a4, content=<a href='/topic/show?id=b54641646ae' target=_blank style='color:#2F92EE;'>#培门冬酶#</a> <a href='/topic/show?id=329c2e376fa' target=_blank style='color:#2F92EE;'>#信迪利单抗#</a> <a href='/topic/show?id=8ae712834d8' target=_blank style='color:#2F92EE;'>#NK/T细胞淋巴瘤#</a>, objectTitle=抗代谢药物培门冬酶联合PD-1抗体信迪利单抗一线治疗NK/T细胞淋巴瘤, objectType=article, longId=817064, objectId=c75781e0649c, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/close-up-of-doctors-with-clipboard-at-hospital-PXE5DKE.jpg, objectUrl=/article/show_article.do?id=c75781e0649c, replyNumber=0, likeNumber=102, createdTime=2024-03-24, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=c75781e0649c, moduleTitle=抗代谢药物培门冬酶联合PD-1抗体信迪利单抗一线治疗NK/T细胞淋巴瘤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c75781e0649c)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2192370, encodeId=12e521923e037, content=<a href='/topic/show?id=329c2e376fa' target=_blank style='color:#2F92EE;'>#信迪利单抗#</a> <a href='/topic/show?id=b54641646ae' target=_blank style='color:#2F92EE;'>#培门冬酶#</a> <a href='/topic/show?id=8ae712834d8' target=_blank style='color:#2F92EE;'>#NK/T细胞淋巴瘤#</a>, objectTitle=【STTT】赵维莅教授团队探索信迪利单抗联合培门冬酶一线治疗晚期NK/T细胞淋巴瘤的疗效及标志物, objectType=article, longId=816559, objectId=28a681655901, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/patient-meeting-a-doctor-PAYSRMZ.jpg, objectUrl=/article/show_article.do?id=28a681655901, replyNumber=0, likeNumber=81, createdTime=2024-03-10, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=28a681655901, moduleTitle=【STTT】赵维莅教授团队探索信迪利单抗联合培门冬酶一线治疗晚期NK/T细胞淋巴瘤的疗效及标志物, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=28a681655901)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2188838, encodeId=f3c32188838df, content=<a href='/topic/show?id=adf23354483' target=_blank style='color:#2F92EE;'>#化疗#</a> <a href='/topic/show?id=329c2e376fa' target=_blank style='color:#2F92EE;'>#信迪利单抗#</a> <a href='/topic/show?id=e2d8111434e1' target=_blank style='color:#2F92EE;'>#鳞状肺癌#</a>, objectTitle=Nat. Commun | 信迪利单抗联合两个周期化疗治疗晚期鳞状非小细胞肺癌：2期临床试验, objectType=article, longId=814335, objectId=de00814335ce, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240222/1708614347045_6145188.jpg, objectUrl=/article/show_article.do?id=de00814335ce, replyNumber=0, likeNumber=76, createdTime=2024-02-23, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=de00814335ce, moduleTitle=Nat. Commun | 信迪利单抗联合两个周期化疗治疗晚期鳞状非小细胞肺癌：2期临床试验, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=de00814335ce)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2185494, encodeId=35de21854940f, content=<a href='/topic/show?id=32af9938ec6' target=_blank style='color:#2F92EE;'>#非小细胞肺癌#</a> <a href='/topic/show?id=329c2e376fa' target=_blank style='color:#2F92EE;'>#信迪利单抗#</a> <a href='/topic/show?id=34b54848271' target=_blank style='color:#2F92EE;'>#帕博利珠单抗#</a>, objectTitle=Science Bulletin：PD-L1表达指导信迪利单抗与帕博利珠单抗单药或联合铂双药化疗在初治晚期非小细胞肺癌患者中的比较, objectType=article, longId=810556, objectId=04b9810556a3, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240122/1705934701224_6145188.png, objectUrl=/article/show_article.do?id=04b9810556a3, replyNumber=0, likeNumber=78, createdTime=2024-02-02, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=04b9810556a3, moduleTitle=Science Bulletin：PD-L1表达指导信迪利单抗与帕博利珠单抗单药或联合铂双药化疗在初治晚期非小细胞肺癌患者中的比较, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=04b9810556a3)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2182828, encodeId=30f4218282862, content=<a href='/topic/show?id=735a81364b7' target=_blank style='color:#2F92EE;'>#肝细胞癌#</a> <a href='/topic/show?id=329c2e376fa' target=_blank style='color:#2F92EE;'>#信迪利单抗#</a>, objectTitle=Nat Med：海军军医大学程树群/刘艳芳发布信迪利单抗在高危肝细胞癌切除术中的辅助应用的最新结果, objectType=article, longId=810182, objectId=92d681018237, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/doctor-in-his-practice-with-a-digital-tablet-UWZKVBN.jpg, objectUrl=/article/show_article.do?id=92d681018237, replyNumber=0, likeNumber=87, createdTime=2024-01-20, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=陕西省, moduleDTOList=[ModuleDTO(moduleId=92d681018237, moduleTitle=Nat Med：海军军医大学程树群/刘艳芳发布信迪利单抗在高危肝细胞癌切除术中的辅助应用的最新结果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=92d681018237)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2174109, encodeId=8e6f21e410925, content=<a href='/topic/show?id=59ed598e816' target=_blank style='color:#2F92EE;'>#晚期胃癌#</a> <a href='/topic/show?id=329c2e376fa' target=_blank style='color:#2F92EE;'>#信迪利单抗#</a>, objectTitle=惠及胃癌“全人群”！JAMA发表一线治疗晚期胃癌中国证据！, objectType=article, longId=804073, objectId=a30d8040e3ce, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/medics-and-patient-on-hospital-gurney-at-PMW6NAQ.jpg, objectUrl=/article/show_article.do?id=a30d8040e3ce, replyNumber=0, likeNumber=93, createdTime=2023-12-10, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=a30d8040e3ce, moduleTitle=惠及胃癌“全人群”！JAMA发表一线治疗晚期胃癌中国证据！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a30d8040e3ce)], followStatus=false, userIsMember=false, type=null, lengthMark=0)] 梅斯话题小助手

信迪利单抗

2020-05-29

梅斯管理员 (审核中...)

前往app查看评论内容

#鼻咽癌# #信迪利单抗#

读书报告 | CONTINUUM研究：信迪利单抗联合同步诱导放化疗治疗中国局部晚期鼻咽癌的3 期临床试验

2024-09-26发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#非小细胞肺癌# #信迪利单抗#

EGFR 19del/T790M/C797S顺式突变耐药非小细胞肺癌获益信迪利单抗/抗VEGF/化疗

2024-09-22发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#甲氨蝶呤# #利妥昔单抗# #替莫唑胺# #原发性中枢神经系统淋巴瘤# #信迪利单抗#

【STTT】信迪利单抗、大剂量甲氨蝶呤、替莫唑胺和利妥昔单抗治疗PCNSL的2期研究

2024-09-09发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#鼻咽癌# #信迪利单抗#

读书报告 | CONTINUUM研究：信迪利单抗联合诱导-同步放化疗治疗中国局部晚期鼻咽癌患者的多中心随机对照的3 期临床试验

2024-09-06发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#胃癌# #生物标志物# #信迪利单抗#

吴昊教授：精准诊疗在胃癌围手术期及晚期的应用

2024-08-26发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#直肠癌# #信迪利单抗# #新辅助同步放化疗#

徐瑞华团队研究荣登《Cancer Cell》：新辅助同步放化疗联合信迪利单抗为pMMR局部进展期直肠癌患者提供新选择！

2024-08-13发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#信迪利单抗# #术前放疗化疗# #pMMR局部晚期结直肠癌#

Cancer Cell | 添加信迪利单抗到术前化疗放疗可显著提高 pMMR 局部晚期直肠癌患者的 CR 率

2024-08-09发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#肝细胞癌# #信迪利单抗#

读书报告 | 信迪利单抗辅助治疗高危肝细胞癌的II期临床研究

2024-06-24发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#西达苯胺# #结外NK/T细胞淋巴瘤# #信迪利单抗#

信迪利单抗联合西达苯胺在复发/难治性结外NK/T细胞淋巴瘤中的Ib/II期研究

2024-05-28发表于上海

梅斯管理员 (审核中...)